SENATE DOCKET, NO. 1777        FILED ON: 1/21/2011

SENATE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 1152

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

Richard T. Moore

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act to promote the elimination of waste in certain state facilities.

_______________

PETITION OF:

 

Name:

District/Address:

Richard T. Moore

 

Robert M. Koczera

11th Bristol

Bruce E. Tarr

 

Geraldo Alicea

6th Worcester

Harriette L. Chandler

 

James B. Eldridge

 

Bradley H. Jones, Jr.

20th Middlesex

Marc R. Pacheco

 


SENATE DOCKET, NO. 1777        FILED ON: 1/21/2011

SENATE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 1152

By Mr. Moore, petition (accompanied by bill, Senate, No. 1152) of Pacheco, Jones, Eldridge and other members of the General Court relative to prescription drug waste [Joint Committee on Public Health].

 

[SIMILAR MATTER FILED IN PREVIOUS SESSION
SEE HOUSE, NO. 4686 OF 2009-2010.]

 

The Commonwealth of Massachusetts

 

_______________

In the Year Two Thousand Eleven

_______________

 

An Act to promote the elimination of waste in certain state facilities.

 

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

                SECTION 1. Chapter 111 of the General Laws is hereby amended by striking out section 25I, as appearing in the 2008 Official Edition, and inserting in place thereof the following section:-

                Section 25I.  The department, in conjunction with the board of registration in pharmacy and the division of medical assistance, shall establish and implement methods to reduce medication waste in facilities licensed by the departments of public health, mental health and corrections. The department shall establish such methods, based on its review, that are determined to be effective in reducing waste without imposing unreasonable costs on the health care delivery system. Such methods may be based on, but not be limited to, the following: (1) current technology, standards and reimbursement mechanisms for dispensing and distributing medications to facilities; (2) other states' requirements for limiting prescription drug waste and any cost savings realized; (3) the commonwealth's standards for the return and re-dispensing of patient-specific schedule VI prescription drugs; and (4) possible incentive mechanisms to prevent the creation of prescription drug waste. The department shall promulgate regulations to implement this section.

                SECTION 2.  The fifth paragraph of section 70E of said chapter 111, as so appearing, is hereby amended by adding the following subsection:-

(p) to obtain from the facility in charge of the patient’s care, upon discharge, any bulk medications that were prescribed for the patient during the patient’s stay including, but not limited to, aerosol inhalers, topical products such as creams and powders eye drops, insulins and special order items, provided that any such items are patient specific and personal and would not otherwise be used in the treatment of another patient.  Upon discharge from the hospital, these bulk items shall be considered the personal property of the patient and at the prescribing physician’s discretion may include in discharge orders that the patient be provided with the specific bulk products that were used in the hospital with use directions.  The department shall promulgate regulations to implement this section.

                SECTION 3.  The department of public health, in consultation with the board of registration in pharmacy shall, as  shall provide to the joint committee on health care financing and the joint committee on public health, on or before  April 1, 2011 a report and legislative recommendations relative to issues of implementation of  the programs established under subsection p of section 70E of chapter 111 and section 25I of chapter 111, including, but not limited to: savings and costs related to the implementation of the programs established and recommendations related to penalties for violations of subsection p of section 70E of chapter 111 and section 25I of chapter 111.